Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 193 to 202 of 202 entries
Sorted by: Best Match Show Resources per page
Towards spatio-temporally resolved developmental cardiac gene regulatory networks in zebrafish.

Briefings in functional genomics

Hallab JC, Nim HT, Stolper J, Chahal G, Waylen L, Bolk F, Elliott DA, Porrello E, Ramialison M.
PMID: 34170300
Brief Funct Genomics. 2021 Jun 25; doi: 10.1093/bfgp/elab030. Epub 2021 Jun 25.

Heart formation in the zebrafish involves a rapid, complex series of morphogenetic events in three-dimensional space that spans cardiac lineage specification through to chamber formation and maturation. This process is tightly orchestrated by a cardiac gene regulatory network (GRN),...

Cite
Hallab JC, Nim HT, Stolper J, et al. Towards spatio-temporally resolved developmental cardiac gene regulatory networks in zebrafish. Brief Funct Genomics. 2021;doi: 10.1093/bfgp/elab030.
Hallab, J. C., Nim, H. T., Stolper, J., Chahal, G., Waylen, L., Bolk, F., Elliott, D. A., Porrello, E., & Ramialison, M. (2021). Towards spatio-temporally resolved developmental cardiac gene regulatory networks in zebrafish. Briefings in functional genomics, . https://doi.org/10.1093/bfgp/elab030
Hallab, Jeannette C, et al. "Towards spatio-temporally resolved developmental cardiac gene regulatory networks in zebrafish." Briefings in functional genomics vol. (2021). doi: https://doi.org/10.1093/bfgp/elab030
Hallab JC, Nim HT, Stolper J, Chahal G, Waylen L, Bolk F, Elliott DA, Porrello E, Ramialison M. Towards spatio-temporally resolved developmental cardiac gene regulatory networks in zebrafish. Brief Funct Genomics. 2021 Jun 25; doi: 10.1093/bfgp/elab030. Epub 2021 Jun 25. PMID: 34170300.
Copy Download .nbib Format: NLM
Inequalities in Physical Activity During the COVID-19 Pandemic: Report on 4 Consecutive Population-Based Surveys in Southern Brazil.

Journal of physical activity & health

Ricardo LIC, Knuth AG, Nunes BP, Hallal PC, Santos LP, Harter J, Pellegrini DDCP, Crochemore-Silva I.
PMID: 34983025
J Phys Act Health. 2022 Jan 04;1-7. doi: 10.1123/jpah.2021-0218. Epub 2022 Jan 04.

BACKGROUND: This study aims to investigate inequalities in leisure-time physical activity (PA) practice amid the COVID-19 pandemic in a southern Brazilian city.METHODS: Four repeated population-based surveys were carried out. PA was collected using a questionnaire proposed by the authors...

Cite
Ricardo LIC, Knuth AG, Nunes BP, et al. Inequalities in Physical Activity During the COVID-19 Pandemic: Report on 4 Consecutive Population-Based Surveys in Southern Brazil. J Phys Act Health. 2022;1-7doi: 10.1123/jpah.2021-0218.
Ricardo, L. I. C., Knuth, A. G., Nunes, B. P., Hallal, P. C., Santos, L. P., Harter, J., Pellegrini, D. D. C. P., & Crochemore-Silva, I. (2022). Inequalities in Physical Activity During the COVID-19 Pandemic: Report on 4 Consecutive Population-Based Surveys in Southern Brazil. Journal of physical activity & health, 1-7. https://doi.org/10.1123/jpah.2021-0218
Ricardo, Luiza Isnardi Cardoso, et al. "Inequalities in Physical Activity During the COVID-19 Pandemic: Report on 4 Consecutive Population-Based Surveys in Southern Brazil." Journal of physical activity & health vol. (2022): 1-7. doi: https://doi.org/10.1123/jpah.2021-0218
Ricardo LIC, Knuth AG, Nunes BP, Hallal PC, Santos LP, Harter J, Pellegrini DDCP, Crochemore-Silva I. Inequalities in Physical Activity During the COVID-19 Pandemic: Report on 4 Consecutive Population-Based Surveys in Southern Brazil. J Phys Act Health. 2022 Jan 04;1-7. doi: 10.1123/jpah.2021-0218. Epub 2022 Jan 04. PMID: 34983025.
Copy Download .nbib Format: NLM
AUTHOR REPLY.

Urology

Prunty M, Bukavina L, Hallman JC.
PMID: 34895596
Urology. 2021 Nov;157:4. doi: 10.1016/j.urology.2021.06.050.

No abstract available.

Cite
Prunty M, Bukavina L, Hallman JC. AUTHOR REPLY. Urology. 2021;157:4doi: 10.1016/j.urology.2021.06.050.
Prunty, M., Bukavina, L., & Hallman, J. C. (2021). AUTHOR REPLY. Urology, 1574. https://doi.org/10.1016/j.urology.2021.06.050
Prunty, Megan, et al. "AUTHOR REPLY." Urology vol. 157 (2021): 4. doi: https://doi.org/10.1016/j.urology.2021.06.050
Prunty M, Bukavina L, Hallman JC. AUTHOR REPLY. Urology. 2021 Nov;157:4. doi: 10.1016/j.urology.2021.06.050. PMID: 34895596.
Copy Download .nbib Format: NLM
Cannabidiol effectively reverses mechanical and thermal allodynia, hyperalgesia, and anxious behaviors in a neuropathic pain model: Possible role of CB1 and TRPV1 receptors.

Neuropharmacology

Silva-Cardoso GK, Lazarini-Lopes W, Hallak JE, Crippa JA, Zuardi AW, Garcia-Cairasco N, Leite-Panissi CRA.
PMID: 34274349
Neuropharmacology. 2021 Oct 01;197:108712. doi: 10.1016/j.neuropharm.2021.108712. Epub 2021 Jul 16.

The incidence of chronic pain is high in the general population and it is closely related to anxiety disorders, which promote negative effects on the quality of life. The cannabinoid system has essential participation in the pain sensitivity circuit....

Cite
Silva-Cardoso GK, Lazarini-Lopes W, Hallak JE, et al. Cannabidiol effectively reverses mechanical and thermal allodynia, hyperalgesia, and anxious behaviors in a neuropathic pain model: Possible role of CB1 and TRPV1 receptors. Neuropharmacology. 2021;197:108712doi: 10.1016/j.neuropharm.2021.108712.
Silva-Cardoso, G. K., Lazarini-Lopes, W., Hallak, J. E., Crippa, J. A., Zuardi, A. W., Garcia-Cairasco, N., & Leite-Panissi, C. R. A. (2021). Cannabidiol effectively reverses mechanical and thermal allodynia, hyperalgesia, and anxious behaviors in a neuropathic pain model: Possible role of CB1 and TRPV1 receptors. Neuropharmacology, 197108712. https://doi.org/10.1016/j.neuropharm.2021.108712
Silva-Cardoso, Gleice K, et al. "Cannabidiol effectively reverses mechanical and thermal allodynia, hyperalgesia, and anxious behaviors in a neuropathic pain model: Possible role of CB1 and TRPV1 receptors." Neuropharmacology vol. 197 (2021): 108712. doi: https://doi.org/10.1016/j.neuropharm.2021.108712
Silva-Cardoso GK, Lazarini-Lopes W, Hallak JE, Crippa JA, Zuardi AW, Garcia-Cairasco N, Leite-Panissi CRA. Cannabidiol effectively reverses mechanical and thermal allodynia, hyperalgesia, and anxious behaviors in a neuropathic pain model: Possible role of CB1 and TRPV1 receptors. Neuropharmacology. 2021 Oct 01;197:108712. doi: 10.1016/j.neuropharm.2021.108712. Epub 2021 Jul 16. PMID: 34274349.
Copy Download .nbib Format: NLM
Optimization of follow-up in patients with papillary thyroid cancer who show no evidence of disease 9-12 months after treatment.

BJS open

Nordell F, Hallal G, Asp P, Almquist M.
PMID: 34882764
BJS Open. 2021 Nov 09;5(6). doi: 10.1093/bjsopen/zrab119.

BACKGROUND: Papillary thyroid cancer (PTC) has an excellent prognosis, and recurrence is rare in patients with no evidence of disease (NED) after initial treatment. Despite this, several guidelines recommend long and costly follow-up, with limited evidence of improved patient...

Cite
Nordell F, Hallal G, Asp P, et al. Optimization of follow-up in patients with papillary thyroid cancer who show no evidence of disease 9-12 months after treatment. BJS Open. 2021;5(6)doi: 10.1093/bjsopen/zrab119.
Nordell, F., Hallal, G., Asp, P., & Almquist, M. (2021). Optimization of follow-up in patients with papillary thyroid cancer who show no evidence of disease 9-12 months after treatment. BJS open, 5(6), . https://doi.org/10.1093/bjsopen/zrab119
Nordell, Fabian, et al. "Optimization of follow-up in patients with papillary thyroid cancer who show no evidence of disease 9-12 months after treatment." BJS open vol. 5,6 (2021). doi: https://doi.org/10.1093/bjsopen/zrab119
Nordell F, Hallal G, Asp P, Almquist M. Optimization of follow-up in patients with papillary thyroid cancer who show no evidence of disease 9-12 months after treatment. BJS Open. 2021 Nov 09;5(6). doi: 10.1093/bjsopen/zrab119. PMID: 34882764; PMCID: PMC8659350.
Copy Download .nbib Format: NLM
Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action.

Journal of psychopharmacology (Oxford, England)

Dos Santos RG, Hallak JE, Baker G, Dursun S.
PMID: 33740877
J Psychopharmacol. 2021 Apr;35(4):453-458. doi: 10.1177/0269881120986422. Epub 2021 Mar 19.

Major depressive disorder (MDD) is among the most prevalent mental health disorders worldwide, and it is associated with a reduced quality of life and enormous costs to health care systems. Available drug treatments show low-to-moderate response in most patients,...

Cite
Dos Santos RG, Hallak JE, Baker G, et al. Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action. J Psychopharmacol. 2021;35(4):453-458doi: 10.1177/0269881120986422.
Dos Santos, R. G., Hallak, J. E., Baker, G., & Dursun, S. (2021). Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action. Journal of psychopharmacology (Oxford, England), 35(4), 453-458. https://doi.org/10.1177/0269881120986422
Dos Santos, Rafael Guimarães, et al. "Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action." Journal of psychopharmacology (Oxford, England) vol. 35,4 (2021): 453-458. doi: https://doi.org/10.1177/0269881120986422
Dos Santos RG, Hallak JE, Baker G, Dursun S. Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action. J Psychopharmacol. 2021 Apr;35(4):453-458. doi: 10.1177/0269881120986422. Epub 2021 Mar 19. PMID: 33740877.
Copy Download .nbib Format: NLM
Optimization of follow-up in patients with papillary thyroid cancer who show no evidence of disease 9-12 months after treatment.

BJS open

Nordell F, Hallal G, Asp P, Almquist M.
PMID: 34882764
BJS Open. 2021 Nov 09;5(6). doi: 10.1093/bjsopen/zrab119.

BACKGROUND: Papillary thyroid cancer (PTC) has an excellent prognosis, and recurrence is rare in patients with no evidence of disease (NED) after initial treatment. Despite this, several guidelines recommend long and costly follow-up, with limited evidence of improved patient...

Cite
Nordell F, Hallal G, Asp P, et al. Optimization of follow-up in patients with papillary thyroid cancer who show no evidence of disease 9-12 months after treatment. BJS Open. 2021;5(6)doi: 10.1093/bjsopen/zrab119.
Nordell, F., Hallal, G., Asp, P., & Almquist, M. (2021). Optimization of follow-up in patients with papillary thyroid cancer who show no evidence of disease 9-12 months after treatment. BJS open, 5(6), . https://doi.org/10.1093/bjsopen/zrab119
Nordell, Fabian, et al. "Optimization of follow-up in patients with papillary thyroid cancer who show no evidence of disease 9-12 months after treatment." BJS open vol. 5,6 (2021). doi: https://doi.org/10.1093/bjsopen/zrab119
Nordell F, Hallal G, Asp P, Almquist M. Optimization of follow-up in patients with papillary thyroid cancer who show no evidence of disease 9-12 months after treatment. BJS Open. 2021 Nov 09;5(6). doi: 10.1093/bjsopen/zrab119. PMID: 34882764; PMCID: PMC8659350.
Copy Download .nbib Format: NLM
Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.

Cannabis and cannabinoid research

Crippa JAS, Pacheco JC, Zuardi AW, Guimarães FS, Campos AC, Osório FL, Loureiro SR, Dos Santos RG, Souza JDS, Ushirohira JM, Ferreira RR, Mancini Costa KC, Scomparin DS, Scarante FF, Pires-Dos-Santos I, Mechoulam R, Kapczinski F, Fonseca BAL, Esposito DLA, Passos ADC, Dal Fabbro AL, Bellissimo-Rodrigues F, Arruda E, Scarpelini S, Andraus MH, Nather Junior JC, Wada DT, Koenigkam-Santos M, Santos AC, Busatto Filho G, Hallak JEC.
PMID: 34619044
Cannabis Cannabinoid Res. 2021 Oct 07; doi: 10.1089/can.2021.0093. Epub 2021 Oct 07.

No abstract available.

Cite
Crippa JAS, Pacheco JC, Zuardi AW, et al. Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Cannabis Cannabinoid Res. 2021;doi: 10.1089/can.2021.0093.
Crippa, J. A. S., Pacheco, J. C., Zuardi, A. W., Guimarães, F. S., Campos, A. C., Osório, F. L., Loureiro, S. R., Dos Santos, R. G., Souza, J. D. S., Ushirohira, J. M., Ferreira, R. R., Mancini Costa, K. C., Scomparin, D. S., Scarante, F. F., Pires-Dos-Santos, I., Mechoulam, R., Kapczinski, F., Fonseca, B. A. L., Esposito, D. L. A., Passos, A. D. C., Dal Fabbro, A. L., Bellissimo-Rodrigues, F., Arruda, E., Scarpelini, S., Andraus, M. H., Nather Junior, J. C., Wada, D. T., Koenigkam-Santos, M., Santos, A. C., Busatto Filho, G., & Hallak, J. E. C. (2021). Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Cannabis and cannabinoid research, . https://doi.org/10.1089/can.2021.0093
Crippa, José Alexandre S, et al. "Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial." Cannabis and cannabinoid research vol. (2021). doi: https://doi.org/10.1089/can.2021.0093
Crippa JAS, Pacheco JC, Zuardi AW, Guimarães FS, Campos AC, Osório FL, Loureiro SR, Dos Santos RG, Souza JDS, Ushirohira JM, Ferreira RR, Mancini Costa KC, Scomparin DS, Scarante FF, Pires-Dos-Santos I, Mechoulam R, Kapczinski F, Fonseca BAL, Esposito DLA, Passos ADC, Dal Fabbro AL, Bellissimo-Rodrigues F, Arruda E, Scarpelini S, Andraus MH, Nather Junior JC, Wada DT, Koenigkam-Santos M, Santos AC, Busatto Filho G, Hallak JEC. Cannabidiol for COVID-19 Patients with Mild to Moderate Symptoms (CANDIDATE Study): A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Cannabis Cannabinoid Res. 2021 Oct 07; doi: 10.1089/can.2021.0093. Epub 2021 Oct 07. PMID: 34619044.
Copy Download .nbib Format: NLM
Corrigendum: Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13.

Frontiers in molecular neuroscience

Falvella ACB, Smith BJ, Silva-Costa LC, Valença AGF, Crunfli F, Zuardi AW, Hallak JE, Crippa JA, de Almeida V, Martins-de-Souza D.
PMID: 34924956
Front Mol Neurosci. 2021 Nov 30;14:814907. doi: 10.3389/fnmol.2021.814907. eCollection 2021.

[This corrects the article DOI: 10.3389/fnmol.2021.673144.].

Cite
Falvella ACB, Smith BJ, Silva-Costa LC, et al. Corrigendum: Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13. Front Mol Neurosci. 2021;14:814907doi: 10.3389/fnmol.2021.814907.
Falvella, A. C. B., Smith, B. J., Silva-Costa, L. C., Valença, A. G. F., Crunfli, F., Zuardi, A. W., Hallak, J. E., Crippa, J. A., de Almeida, V., & Martins-de-Souza, D. (2021). Corrigendum: Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13. Frontiers in molecular neuroscience, 14814907. https://doi.org/10.3389/fnmol.2021.814907
Falvella, Ana Caroline Brambilla, et al. "Corrigendum: Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13." Frontiers in molecular neuroscience vol. 14 (2021): 814907. doi: https://doi.org/10.3389/fnmol.2021.814907
Falvella ACB, Smith BJ, Silva-Costa LC, Valença AGF, Crunfli F, Zuardi AW, Hallak JE, Crippa JA, de Almeida V, Martins-de-Souza D. Corrigendum: Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13. Front Mol Neurosci. 2021 Nov 30;14:814907. doi: 10.3389/fnmol.2021.814907. eCollection 2021. PMID: 34924956; PMCID: PMC8672415.
Copy Download .nbib Format: NLM
Robotic pancreas surgery: an overview of history and update on technique, outcomes, and financials.

Journal of robotic surgery

Khachfe HH, Habib JR, Harthi SA, Suhool A, Hallal AH, Jamali FR.
PMID: 34357526
J Robot Surg. 2021 Aug 06; doi: 10.1007/s11701-021-01289-2. Epub 2021 Aug 06.

The use robotics in surgery is gaining momentum. This approach holds substantial promise in pancreas surgery. Robotic surgery for pancreatic lesions and malignancies has become well accepted and is expanding to more and more center annually. The number of...

Cite
Khachfe HH, Habib JR, Harthi SA, et al. Robotic pancreas surgery: an overview of history and update on technique, outcomes, and financials. J Robot Surg. 2021;doi: 10.1007/s11701-021-01289-2.
Khachfe, H. H., Habib, J. R., Harthi, S. A., Suhool, A., Hallal, A. H., & Jamali, F. R. (2021). Robotic pancreas surgery: an overview of history and update on technique, outcomes, and financials. Journal of robotic surgery, . https://doi.org/10.1007/s11701-021-01289-2
Khachfe, Hussein H, et al. "Robotic pancreas surgery: an overview of history and update on technique, outcomes, and financials." Journal of robotic surgery vol. (2021). doi: https://doi.org/10.1007/s11701-021-01289-2
Khachfe HH, Habib JR, Harthi SA, Suhool A, Hallal AH, Jamali FR. Robotic pancreas surgery: an overview of history and update on technique, outcomes, and financials. J Robot Surg. 2021 Aug 06; doi: 10.1007/s11701-021-01289-2. Epub 2021 Aug 06. PMID: 34357526.
Copy Download .nbib Format: NLM
Showing 193 to 202 of 202 entries